Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen

Stopped slow inclusion, due to difficulties in obtaining the patients consent for the 2 months invasive follow-up, as required by protocol design.

Conditions

• Stable Coronary Disease
• Unstable Coronary Disease
• Documented Silent Ischemia

Interventions

• DEVICE: Drug Eluting Stent

Sponsor

CID - Carbostent & Implantable Devices

Collaborators

• [object Object]